Deutsche Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,400
Closed -$5.67M 3668
2024
Q3
$5.67M Buy
+6,400
New +$5.75M ﹤0.01% 1233
2017
Q2
Sell
-250
Closed -$21K 5032
2017
Q1
$21K Buy
+250
New +$20K ﹤0.01% 4494
2016
Q4
Sell
-700
Closed -$56K 4998
2016
Q3
$56K Sell
700
-500
-42% -$40K ﹤0.01% 4171
2016
Q2
$94K Sell
1,200
-885
-42% -$66.6K ﹤0.01% 4142
2016
Q1
$150K Buy
+2,085
New +$158K ﹤0.01% 3785
2015
Q4
Sell
-40
Closed -$3K 5353
2015
Q3
$3K Buy
+40
New +$3.38K ﹤0.01% 5085
2014
Q4
Sell
-1,000
Closed -$64K 6246
2014
Q3
$64K Buy
+1,000
New +$63.3K ﹤0.01% 4728
2013
Q4
Sell
-1,728
Closed -$4K 5566
2013
Q3
$4K Buy
+1,728
New +$90.5K ﹤0.01% 5216

Other funds holding LLY

Deutsche Bank's LLY Position: Q1 2026 in Review

Deutsche Bank reduced its Eli Lilly (LLY) stake by 6.8% in Q1 2026, selling an estimated $263M and leaving 3,547,772 shares worth $3.26B. The position accounts for 1.08% of the portfolio, ranked #11.

Deutsche Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.09B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Deutsche Bank held 3,547,772 shares of Eli Lilly worth $3.26B as of Q1 2026.
  • Deutsche Bank sold 259,865 Eli Lilly shares in Q1 2026, an estimated $263M.
  • Eli Lilly made up 1.08% of Deutsche Bank's portfolio in Q1 2026, its #11 holding.
  • Deutsche Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Eli Lilly position peaked at $4.09B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.